1. Home
  2. ACTG vs ASMB Comparison

ACTG vs ASMB Comparison

Compare ACTG & ASMB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Acacia Research Corporation (Acacia Tech)

ACTG

Acacia Research Corporation (Acacia Tech)

HOLD

Current Price

$5.02

Market Cap

384.9M

Sector

Miscellaneous

ML Signal

HOLD

Logo Assembly Biosciences Inc.

ASMB

Assembly Biosciences Inc.

HOLD

Current Price

$29.22

Market Cap

440.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ACTG
ASMB
Founded
1993
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Multi-Sector Companies
Biotechnology: Pharmaceutical Preparations
Sector
Miscellaneous
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
384.9M
440.0M
IPO Year
1995
2010

Fundamental Metrics

Financial Performance
Metric
ACTG
ASMB
Price
$5.02
$29.22
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
5
Target Price
$6.00
$43.40
AVG Volume (30 Days)
455.8K
57.2K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
161.11
91.78
EPS
0.22
N/A
Revenue
$12,004,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$274.75
P/E Ratio
$22.73
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.70
$7.90
52 Week High
$5.21
$39.71

Technical Indicators

Market Signals
Indicator
ACTG
ASMB
Relative Strength Index (RSI) 64.88 53.66
Support Level $4.77 $26.71
Resistance Level $5.21 $30.54
Average True Range (ATR) 0.16 1.47
MACD -0.02 0.11
Stochastic Oscillator 56.18 73.59

Price Performance

Historical Comparison
ACTG
ASMB

About ACTG Acacia Research Corporation (Acacia Tech)

Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, capital base, and deep industry relationships to drive value. The company has four reportable business segments: Intellectual Property Operations, Industrial Operations, Energy Operations and Manufacturing Operations. It derives revenue from Intellectual Property Operations segment. Geographically, it operates in Americas, Europe, Middle East and Africa, China, India, and Asia-Pacific, excluding China and India.

About ASMB Assembly Biosciences Inc.

Assembly Biosciences Inc is a clinical-stage biotechnology company. It is advancing two platform programs, a novel class of oral therapeutics for the treatment of hepatitis B virus (HBV) infection and novel class of oral synthetic live biotherapeutics, which are designed to restore health to a dysbiotic microbiome. The company's HBV-cure program is aimed at increasing the current low cure rate for patients with HBV and is pursuing multiple drug candidates that inhibit multiple steps of the HBV lifecycle. Assembly has discovered several novel core protein Allosteric Modulators, which are small molecules that directly target and allosterically modulate the HBV core protein. The majority of the revenue is generated from the HBV cure program.

Share on Social Networks: